MyJanssenCarePath.com

SIGN UP LOG IN

Your Personal Account for online access to:

  • Check your insurance coverage
  • Enroll in Savings Program, if eligible
  • Sign up for treatment reminders

Paying for ERLEADA™

Paying for ERLEADA™

Helping make ERLEADA™ more affordable for eligible patients

No matter what type of insurance you have – or even if you don't have insurance – Janssen CarePath can help explain your medication insurance coverage and benefits. We can also help find programs that may help with your ERLEADA™ out-of-pocket costs.

If you use commercial or private health insurance to pay for your medication:

The Janssen CarePath Savings Program may provide an instant savings on your out-of-pocket costs for ERLEADA™. Depending on your health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. If eligible, you will pay $10 per month, $15,000 maximum program benefit per calendar year or one-year supply, whichever comes first. This program is not available to individuals who use any state or federal government-subsidized healthcare program to cover a portion of medication costs, such as Medicare, Medicaid, TRICARE, Department of Defense, or Veterans Administration. For full eligibility requirements, click here.

To learn more, go to your personal Janssen CarePath Account – MyJanssenCarePath.com. If you believe you are eligible for Janssen CarePath Savings Program, go to your account and enroll or call a Janssen CarePath Care Coordinator at 1-833-ERLEADA (375-3232).

If your specialty pharmacy is unable to process your card, you can complete, sign and return the rebate form (instructions on form), with required proof of purchase, to receive your rebate benefit. Click here to get the rebate form.

If you are using government insurance to pay for your medication:

Janssen CarePath can provide information about independent resources that may be able to help with your out-of-pocket medication costs.

JanssenPrescriptionAssistance.com provides information on affordability programs and up-to-date information about independent foundations that may have funding available to help you with medication costs for ERLEADA™.

If you are enrolled in Medicare and using Medicare insurance to pay for your medication, our Medicare Resource Guide provides additional information on sources for cost support that may be available for you.

Get Medicare Resource Guide

Call a Janssen CarePath Care Coordinator at 1-833-ERLEADA (375-3232) for more information.

If you have no health insurance or no coverage for ERLEADA™:

Janssen CarePath can provide information about independent resources that may be able to help with your out-of-pocket medication costs.

JanssenPrescriptionAssistance.com provides information on affordability programs and up-to-date information about independent foundations that may have funding available to help you with medication costs for ERLEADA™.

Call a Janssen CarePath Care Coordinator at 1-833-ERLEADA (375-3232) about affordability programs that may be available.

Other Resources

The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, non-profit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies. To see if you might qualify for assistance, please contact a JJPAF program specialist at 1-800-652-6227 (9 AM to 6 PM ET) or visit the foundation website at www.JJPAF.org.

What is ERLEADA™?

ERLEADA™ (apalutamide) is a prescription medicine used to treat prostate cancer that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone.

It is not known if ERLEADA™ is safe or effective in children.

Important Safety Information For ERLEADA

Do not take ERLEADA™ (apalutamide) if you:

  • are pregnant or may become pregnant. ERLEADA™ may harm your unborn baby.
  • are female. ERLEADA™ is not for use in women.

Before taking ERLEADA™, tell your healthcare provider about all your medical conditions, including if you:

  • have a history of seizures, brain injury, stroke, or brain tumors.
  • have a partner who is pregnant or may become pregnant. Men who are sexually active with a pregnant woman must use a condom during and for 3 months after treatment with ERLEADA™. If your sexual partner may become pregnant, effective birth control (contraception) must be used during and for 3 months after treatment. Talk with your healthcare provider if you have questions about birth control.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ERLEADA™ can interact with many other medicines.

You should not start or stop any medicine before you talk with the healthcare provider that prescribed ERLEADA™.

Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.

How should I take ERLEADA™?

  • Take ERLEADA™ exactly as your healthcare provider tells you.
  • Take your prescribed dose of ERLEADA™ 1 time a day, at the same time each day.
  • Take ERLEADA™ with or without food.
  • Swallow ERLEADA™ tablets whole.
  • Your healthcare provider may change your dose if needed.
  • Do not stop taking your prescribed dose of ERLEADA™ without talking with your healthcare provider first.
  • If you miss a dose of ERLEADA™, take your normal dose as soon as possible on the same day. Return to your normal schedule on the following day. You should not take extra tablets to make up the missed dose.
  • You should start or continue a gonadotropin-releasing hormone (GnRH) analog therapy during your treatment with ERLEADA™ unless you had a surgery to lower the amount of testosterone in your body (surgical castration).
  • If you take too much ERLEADA™, call your healthcare provider or go to the nearest hospital emergency room.
  • Your healthcare provider may do blood tests to check for side effects.

What are the possible side effects of ERLEADA™?

ERLEADA™ may cause serious side effects including:

  • Falls and fractures. ERLEADA™ treatment can cause bones and muscles to weaken and may increase your risk for falls and fractures. Falls and fractures have happened in people during treatment with ERLEADA™. Falls were not caused by loss of consciousness (fainting) or seizures. Your healthcare provider will monitor your risks for falls and fractures during treatment with ERLEADA™.
  • Seizure. If you take ERLEADA™, you may be at risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others. Tell your healthcare provider right away if you have a loss of consciousness or seizure. Your healthcare provider will stop ERLEADA™ if you have a seizure during treatment.

The most common side effects of ERLEADA™ include:

  • feeling very tired
  • high blood pressure
  • rash
  • diarrhea
  • nausea
  • decreased appetite
  • weight loss
  • joint pain
  • fall
  • hot flash
  • bone injury (fracture)
  • swollen hands, ankles, or feet

ERLEADA™ may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility. Do not donate sperm during treatment with ERLEADA™ and for 3 months after the last dose of ERLEADA™.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of ERLEADA™.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see the full Prescribing Information for ERLEADA™.

cp-50508